ROBO4 and Hyperkalemia: Given that the aldosterone-sensitive-distal nephrons are the primary site of K+ secretion, this well-established indirect mechanism likely plays a dominant role in promoting kaliuresis and alleviating hyperkalemia under MRB therapy (Palmer and Clegg, 2024; Neuen et al., 2022, Ishigami et al., 2020).